ArticleCell reports2023

Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression.

Ramiro A Ramirez-Valdez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.